Mazen Taman

Dr. Mazen Taman

Neurosurgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Mazen TamanMazen Taman
Mazen Taman
HAHael Abdulrazeq
Hael Abdulrazeq
CCCarlin Chuck
Carlin Chuck
RSRahul A. Sastry
Rahul A. Sastry
RARohaid Ali
Rohaid Ali
JFJared Fridley
Jared Fridley
Acute spinal cord injury (SCI) often results in severe neurologic deficits, with hemodynamic instability contributing to secondary ischemic damage. Beyond surgical decompression, maintaining adequate mean arterial pressure (MAP) is key to enhancing spinal cord perfusion and oxygenation. Vasopressor therapy is frequently used to achieve hemodynamic stability, but optimal MAP targets and vasopressor selection remain controversial. This review explores updated guidelines and current evidence regarding MAP management and the use of vasopressors in SCI, focusing on their impact on spinal cord perfusion and neurologic outcomes. Recent studies highlight the role of durotomy in directly improving spinal cord perfusion pressure (SCPP) by reducing intraspinal pressure (ISP), offering a complementary mechanical intervention as part of pharmacologic therapies. Recent guidelines suggest an MAP range of 75–80 mmHg as a lower limit and 90–95 mmHg as an upper limit for 3–7 days post-injury, highlighting the need for personalized hemodynamic management. Norepinephrine is commonly preferred due to its balanced effects on peripheral vascular resistance and spinal cord perfusion pressure (SCPP), though dopamine, phenylephrine, and dobutamine each offer unique hemodynamic profiles suited to specific clinical scenarios. Despite their benefits, vasopressors carry significant risks, including arrhythmias and potential myocardial strain, necessitating careful selection based on individual patient factors. Further research is needed to refine vasopressor use and establish evidence-based protocols that optimize neurologic recovery, alongside continued exploration of SCPP as a potential therapeutic target.

27 June 2024 in Neurosurgery Practice
Verified
Journal Article
Open access
HAHael Abdulrazeq
Hael Abdulrazeq
Mazen TamanMazen Taman
Mazen Taman
RARohaid Ali
Rohaid Ali
CDCody Doberstein
Cody Doberstein
PSPatricia L Sullivan
Patricia L Sullivan
WAWael Asaad
Wael Asaad
BACKGROUND AND OBJECTIVES: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have gained increasing popularity since the approval of semaglutide by the United States Food and Drug Administration for chronic weight management. Significant benefits have been noted in glycemic control and cardiovascular health. However, as increasing numbers of patients are started on these medications, it is important for neurosurgeons to have knowledge of any perioperative considerations and side effects related to this class of drugs. METHODS: We performed a qualitative literature review using the PubMed and Embase databases, using the following key words: GLP-1 RAs adverse events; GLP-1 RAs and anesthesia; substance use disorders; and addiction, functional neurosurgery, nervous system rehabilitation, and spinal cord injury. Articles of relevance to perioperative management of these medications and specific benefits in the neurosurgical field were discussed. RESULTS: Recent guidance from the American Society of Anesthesiologists demonstrates the importance of tailored management of GLP-RA drugs for surgical patients. In addition, certain positive effects have been noted with relation to substance use disorders, neural protection and rehabilitation, and neurodegenerative disorders such as Alzheimer's disease. CONCLUSION: In this article, we review what the neurosurgeon needs to know about the perioperative management of GLP-1 RAs and discuss existing literature in clinical and preclinical studies for potential indications and benefits of these medications, which can influence the management of conditions treated by neurosurgeons.

12 January 2026 in Neuro-Oncology Advances
Verified
Journal Article
Open access
CCCarlin Chuck
Carlin Chuck
Mazen TamanMazen Taman
Mazen Taman
TKTrenton Kite
Trenton Kite
ALAlice Lin
Alice Lin
NANatalie Amaral-Nieves
Natalie Amaral-Nieves
CCClark C. Chen
Clark C. Chen
Background: Cesium-131 collagen tile has gained traction as an intraoperative brachytherapy platform for recurrent intracranial tumors, but outcome data in newly diagnosed brain metastases (nBM) remain sparse, with fewer than ten cases reported. This study evaluates the safety and efficacy of cesium-131 collagen tiles in nBM patients. Methods: Clinical information was collected for consecutive nBM patients treated at three neurosurgical centers. Local control and overall survival (OS) were calculated. Results: The cohort comprised 36 patients (14 men, 22 women; mean age, 62.1 ± 8.9 years) with 39 nBM. Histologies included lung (n = 19), melanoma (n = 8), breast (n = 4), gastrointestinal (n = 3), and genitourinary (n = 5) metastases. The mean pre-operative tumor diameter was 3.29 ± 1.35 cm. Gross total resection was achieved in all but one case. Mean Karnofsky Performance Score (KPS) before resection/tile implant was 81 ± 11.1. The average hospital stay was 2.2 ± 1.6 days. Thirty-day and 90-day readmission rates were 25.0% and 19.4%, respectively; there were no unplanned returns to the operating room. With a median follow-up of 328 days, one-year actuarial local control was 100%, with one recurrence at two years. Median overall survival (OS) was 182 days. Radiation necrosis was observed in one patient (2.6%). KPS improved or remained stable in 28 patients (77.8%) and declined in 8 (22.2%). A decline in KPS at one month post-procedure was associated with shorter OS (65 vs. 211 days; P = .02). Conclusion: This multi-institutional study provides the first dedicated evaluation of cesium-131 collagen tiles for the treatment of nBM, demonstrating excellent safety and local control.

21 April 2025 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
VAVivek M. Abraham
Vivek M. Abraham
NSNelson Sofoluke
Nelson Sofoluke
VMVyacheslav Makler
Vyacheslav Makler
GMGino Mongelluzzo
Gino Mongelluzzo
SBSean M. Barber
Sean M. Barber
SKSanjay Konakondla
Sanjay Konakondla
BACKGROUND: Atlantoaxial pseudoarticulation is a rare condition characterized by atypical joint formation at C1–2, potentially causing severe neck pain and progressive cervical myelopathy due to spinal cord compression. Traditional treatments often involve decompression with or without fusion and can lead to significant tissue disruption and extended recovery time. Here, the authors describe a novel, minimally invasive full endoscopic technique for resecting atlantoaxial pseudoarticulation, achieving successful spinal decompression. OBSERVATIONS: A 44-year-old female patient presented with 6 months of progressive cervical myelopathy, including gait instability, right-sided weakness, and numbness. Imaging confirmed a C1–2 pseudoarticulation causing severe spinal cord compression. A paraspinal endoscopic approach was used, avoiding the need for instrumented fusion. Postoperatively, the patient’s condition rapidly improved, with complete symptom resolution at 6 months and only mild intermittent hand numbness at 18 months. Imaging confirmed stable, effective decompression without complications. LESSONS: This case represents the first documented application of a full endoscopic approach for atlantoaxial pseudoarticulation, achieving effective decompression while preserving spinal integrity and reducing recovery time. This technique offers a promising, minimally invasive alternative for complex cervical pathologies, supporting a shift toward less invasive, tissue-sparing spinal surgery. https://thejns.org/doi/10.3171/CASE24766

25 April 2026 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
JOJoseph A. Oldam
Joseph A. Oldam
Mazen TamanMazen Taman
Mazen Taman
WLWeston Crowell de Lomba
Weston Crowell de Lomba
CSChristian Schroeder
Christian Schroeder
OLOwen Leary
Owen Leary
PSPatricia L. Zadnik Sullivan
Patricia L. Zadnik Sullivan
Frailty indices are established tools for estimating long-term survival in oncology, yet their utility for predicting short-term surgical outcomes remains less defined. This study evaluates several frailty, comorbidity, and risk indices for predicting postoperative care needs and other short-term outcomes in patients undergoing spinal metastasis resection. A retrospective cohort study was performed on patients undergoing surgery for spinal metastasis at a tertiary spine center. Preoperative risk was assessed using the modified 5-item frailty index (mFI-5), Metastatic Spinal Tumor Frailty Index (MSTFI), modified Charlson Comorbidity Index (CCI), New England Spinal Metastasis Score (NESMS), modified Bauer score (mBauer), and Spinal Instability Neoplastic Score (SINS). Multivariate logistic regression evaluated associations between indices and nonroutine discharge, prolonged length of stay (LOS), and reoperation, as well as other secondary outcomes. Among 114 patients (mean age 65.6±10.7 years; 57.9% male), 57.0% were discharged to nonroutine settings, 16.7% underwent reoperation, and the mean length of stay was 11.1±10.8 days. MSTFI was independently associated with nonroutine discharge (OR=2.81, 95% CI [1.64–4.84], p<.001) but not prolonged LOS (OR=1.51 [0.99–2.30], p=.055). NESMS was also associated with nonroutine discharge (OR=0.49 [0.28–0.87], p=.015). Secondary analyses identified associations of NESMS spine-related complications (OR=0.46 [0.24–0.87], p=.017) and 90-day mortality (OR=0.48 [0.23–0.98], p=.045). No index significantly predicted reoperation. ROC analysis demonstrated that MSTFI and NESMS outperformed other indices for nonroutine discharge and prolonged LOS; DeLong’s were equivocal. In this single-center surgical cohort, MSTFI and NESMS were the most consistent risk-stratification tools for short-term outcomes, particularly discharge disposition and LOS. Secondary analyses suggested additional associations of NESMS with spine-related complications and 90-day mortality, whereas no index reliably predicted reoperation. Incorporating MSTFI and/or NESMS into preoperative assessment may improve risk stratification and perioperative planning.

23 April 2026 in Clinical Case Reports
Verified
Journal Article
Open access
Mazen TamanMazen Taman
Mazen Taman
CPCarl Porto
Carl Porto
JLJean‐Luc Lewis
Jean‐Luc Lewis
DFDimitrios Farmakiotis
Dimitrios Farmakiotis
AMAthar N. Malik
Athar N. Malik
A previously healthy 19‐year‐old male presented with 1 day of transient right‐sided weakness, numbness, and gait disequilibrium after recent self‐limited sinonasal symptoms and minor nasal trauma with epistaxis. He was afebrile but with focal deficits, leukocytosis, and elevated C‐reactive protein. Noncontrast head CT showed a left frontal lesion with vasogenic edema; MRI demonstrated a 2.4 × 1.4 cm rim‐enhancing lesion in the left paramedian precentral gyrus with homogeneous diffusion restriction, low apparent diffusion coefficient, and surrounding edema. Stereotactic aspiration was performed within 24 h of presentation to obtain microbiological diagnosis and source control. A neuronavigated, transgyral frontal approach was used to avoid eloquent cortex. Empiric antimicrobials were initiated immediately after operative sampling. Postoperatively, the patient developed transient distal right lower extremity weakness that improved with supportive care and physical therapy. A thorough cardiac, dental, and thoracic evaluation did not reveal a source; the case was deemed cryptogenic. Operative cultures grew Streptococcus intermedius and Aggregatibacter aphrophilus . Targeted intravenous therapy was administered with near‐complete radiographic resolution and full neurologic recovery at 4‐month follow‐up. This case emphasizes three practical principles for trainees: maintain suspicion for intracranial infection in afebrile young patients with new focal deficits and recent sinonasal symptoms; prioritize microbiological diagnosis and source control, while not delaying empiric therapy; and plan stereotactic trajectories that respect eloquent cortex and anticipate transient postoperative deficits. Early imaging, meticulous source evaluation and control, and directed therapy remain central to outcome.